Orbifloxacin
Jump to navigation
Jump to search
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATCvet code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.166.510 |
Chemical and physical data | |
Formula | C19H20F3N3O3 |
Molar mass | 395.382 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Orbifloxacin (brand name Orbax) is a fluoroquinolone antibiotic which is approved for use in dogs,[1][2] marketed by Schering-Plough Animal Health.
See also
References
- ^ "Product Abstract - NADA 141-081". American College of Veterinary Clinical Pharmacology. Retrieved 21 June 2008.[dead link]
- ^ Papich MG (October 2020). "Orbifloxacin". Papich Handbook of Veterinary Drugs (Fifth ed.). St. Louis, Missouri: Elsevier Health Sciences. p. 674. ISBN 978-0-323-70958-3.
Categories:
- All articles with dead external links
- Articles with dead external links from September 2023
- Articles with short description
- Short description matches Wikidata
- Drugs with non-standard legal status
- Articles with changed CASNo identifier
- ECHA InfoCard ID from Wikidata
- Chemical pages without DrugBank identifier
- Drugboxes which contain changes to verified fields
- Fluoroquinolone antibiotics
- Cyclopropanes
- Dog medications
- 1,4-di-hydro-7-(1-piperazinyl)-4-oxo-3-quinolinecarboxylic acids
- All stub articles
- Antibiotic stubs
- Veterinary medicine stubs